Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]GP1 PET/CT for Acute Deep Vein Thrombosis
NCT04156230Phase 2Completed
- Start
- Jan 2020
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of 18F-GP1 in deep vein thrombosis (DVT). Primary endpoint: Sensitivity of qualitative [18F]GP1 PET/CT interpretation for the diagnosis of patients with acute proximal deep vein thrombosis. Started Jan 2020; status: completed.
02
Drugs
18F-GP1
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT04156230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156230.